IDEXX LABORATORIES Reports Officer/Director Changes & Compensation Updates
Ticker: IDXX · Form: 8-K · Filed: Dec 12, 2024 · CIK: 874716
| Field | Detail |
|---|---|
| Company | Idexx Laboratories Inc /De (IDXX) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation, governance
Related Tickers: IDXX
TL;DR
IDXX leadership shakeup: new directors elected, exec comp adjusted.
AI Summary
IDEXX LABORATORIES, INC. (IDXX) filed an 8-K on December 12, 2024, reporting changes effective December 6, 2024. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for certain officers. Specific names of departing and newly elected individuals, along with details of the compensatory arrangements, are provided within the filing.
Why It Matters
This filing signals potential shifts in the company's leadership and governance structure, which could influence strategic direction and executive compensation policies.
Risk Assessment
Risk Level: medium — Changes in key personnel and executive compensation can indicate internal shifts that may impact future performance or strategy.
Key Players & Entities
- IDEXX LABORATORIES, INC. (company) — Registrant
- IDXX (company) — Ticker Symbol
- December 6, 2024 (date) — Effective date of changes
- December 12, 2024 (date) — Filing date
FAQ
Who are the specific officers and directors who have departed from IDEXX LABORATORIES, INC. as reported in this 8-K?
The filing indicates the departure of certain officers and directors, but the specific names are detailed within the document's sections concerning Item 5.02.
Which individuals have been elected as new directors to the board of IDEXX LABORATORIES, INC.?
The election of new directors is reported under Item 5.02 of the 8-K filing, with their names and relevant details provided therein.
What are the key changes to the compensatory arrangements for certain officers mentioned in the filing?
The filing addresses updates to compensatory arrangements for certain officers under Item 5.02, with specific details of these arrangements available within the full document.
What is the effective date of the reported changes in directors and officers for IDEXX LABORATORIES, INC.?
The earliest event reported, which includes the departure of directors/officers and the election of new ones, has an effective date of December 6, 2024.
What is the primary purpose of this 8-K filing for IDEXX LABORATORIES, INC.?
This 8-K filing serves as a current report to disclose the departure of certain officers and directors, the election of new directors, and changes to compensatory arrangements for certain officers, effective December 6, 2024.
Filing Stats: 1,004 words · 4 min read · ~3 pages · Grade level 14.3 · Accepted 2024-12-12 16:00:19
Key Financial Figures
- $0.10 — ange on which registered Common Stock, $0.10 par value per share IDXX NASDAQ Global
Filing Documents
- idxx-20241206.htm (8-K) — 30KB
- idxx-20241206_g1.jpg (GRAPHIC) — 47KB
- 0000874716-24-000150.txt ( ) — 289KB
- idxx-20241206.xsd (EX-101.SCH) — 2KB
- idxx-20241206_def.xml (EX-101.DEF) — 15KB
- idxx-20241206_lab.xml (EX-101.LAB) — 26KB
- idxx-20241206_pre.xml (EX-101.PRE) — 15KB
- idxx-20241206_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEXX LABORATORIES, INC. Date: December 12, 2024 By: /s/ Sharon E. Underberg Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary 2